Evaluating the effect of care around labor and delivery practices on early neonatal mortality in the Global Network's Maternal and Newborn Health Registry.

Composite index Early neonatal mortality Early neonatal period Essential newborn care Global network Intrapartum care Labor and delivery care Low income countries Lower middle-income countries Neonatal mortality Newborn care Postpartum care Quality of care

Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
30 Nov 2020
Historique:
received: 01 10 2020
accepted: 05 10 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 22 6 2021
Statut: epublish

Résumé

Neonatal deaths in first 28-days of life represent 47% of all deaths under the age of five years globally and are a focus of the United Nation's (UN's) Sustainable Development Goals. Pregnant women are delivering in facilities but that does not indicate quality of care during delivery and the postpartum period. The World Health Organization's Essential Newborn Care (ENC) package reduces neonatal mortality, but lacks a simple and valid composite index that measures its effectiveness. Data on 5 intra-partum and 3 post-partum practices (indicators) recommended as part of ENC, routinely collected in NICHD's Global Network's (GN) Maternal Newborn Health Registry (MNHR) between 2010 and 2013, were included. We evaluated if all 8 practices (Care around Delivery - CAD), combined as an index was associated with reduced early neonatal mortality rates (days 0-6 of life). A total of 150,848 live births were included in the analysis. The individual indicators varied across sites. All components were present in 19.9% births (range 0.4 to 31% across sites). Present indicators (8 components) were associated with reduced early neonatal mortality [adjusted RR (95% CI):0.81 (0.77, 0.85); p < 0.0001]. Despite an overall association between CAD and early neonatal mortality (RR < 1.0 for all early mortality): delivery by skilled birth attendant; presence of fetal heart and delayed bathing were associated with increased early neonatal mortality. Present indicators (8 practices) of CAD were associated with a 19% reduction in the risk of neonatal death in the diverse health facilities where delivery occurred within the GN MNHR. These indicators could be monitored to identify facilities that need to improve compliance with ENC practices to reduce preventable neonatal deaths. Three of the 8 indicators were associated with increased neonatal mortality, due to baby being sick at birth. Although promising, this composite index needs refinement before use to monitor facility-based quality of care in association with early neonatal mortality. Trial registration The identifier of the Maternal Newborn Health Registry at ClinicalTrials.gov is NCT01073475.

Sections du résumé

BACKGROUND BACKGROUND
Neonatal deaths in first 28-days of life represent 47% of all deaths under the age of five years globally and are a focus of the United Nation's (UN's) Sustainable Development Goals. Pregnant women are delivering in facilities but that does not indicate quality of care during delivery and the postpartum period. The World Health Organization's Essential Newborn Care (ENC) package reduces neonatal mortality, but lacks a simple and valid composite index that measures its effectiveness.
METHODS METHODS
Data on 5 intra-partum and 3 post-partum practices (indicators) recommended as part of ENC, routinely collected in NICHD's Global Network's (GN) Maternal Newborn Health Registry (MNHR) between 2010 and 2013, were included. We evaluated if all 8 practices (Care around Delivery - CAD), combined as an index was associated with reduced early neonatal mortality rates (days 0-6 of life).
RESULTS RESULTS
A total of 150,848 live births were included in the analysis. The individual indicators varied across sites. All components were present in 19.9% births (range 0.4 to 31% across sites). Present indicators (8 components) were associated with reduced early neonatal mortality [adjusted RR (95% CI):0.81 (0.77, 0.85); p < 0.0001]. Despite an overall association between CAD and early neonatal mortality (RR < 1.0 for all early mortality): delivery by skilled birth attendant; presence of fetal heart and delayed bathing were associated with increased early neonatal mortality.
CONCLUSIONS CONCLUSIONS
Present indicators (8 practices) of CAD were associated with a 19% reduction in the risk of neonatal death in the diverse health facilities where delivery occurred within the GN MNHR. These indicators could be monitored to identify facilities that need to improve compliance with ENC practices to reduce preventable neonatal deaths. Three of the 8 indicators were associated with increased neonatal mortality, due to baby being sick at birth. Although promising, this composite index needs refinement before use to monitor facility-based quality of care in association with early neonatal mortality. Trial registration The identifier of the Maternal Newborn Health Registry at ClinicalTrials.gov is NCT01073475.

Identifiants

pubmed: 33256790
doi: 10.1186/s12978-020-01010-w
pii: 10.1186/s12978-020-01010-w
pmc: PMC7708898
doi:

Banques de données

ClinicalTrials.gov
['NCT01073475']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156

Subventions

Organisme : NICHD NIH HHS
ID : UG1 HD076461
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076474
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078439
Pays : United States

Références

Clin Perinatol. 2013 Dec;40(4):601-10
pubmed: 24182950
Matern Health Neonatol Perinatol. 2019 Mar 1;5:3
pubmed: 30867935
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
BMC Pregnancy Childbirth. 2014 Mar 07;14:99
pubmed: 24606612
Cochrane Database Syst Rev. 2003;(2):CD002771
pubmed: 12804436
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S5-18, S19
pubmed: 19815202
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
BMC Pregnancy Childbirth. 2019 Apr 16;19(1):133
pubmed: 30991979
BMC Pregnancy Childbirth. 2012 Oct 29;12:118
pubmed: 23106962
Trials. 2016 Dec 7;17(1):576
pubmed: 27923401
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
Clin Perinatol. 2014 Dec;41(4):749-72
pubmed: 25459772
Int J Gynaecol Obstet. 2012 Sep;118(3):190-3
pubmed: 22738806
Pediatrics. 2006 Mar;117(3):e380-6
pubmed: 16510618
N Engl J Med. 2017 Dec 14;377(24):2313-2324
pubmed: 29236628
Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Lancet Glob Health. 2019 May;7(5):e624-e632
pubmed: 30898495
BJOG. 2015 Jul;122(8):1045-9
pubmed: 25929823
Reprod Health. 2015;12 Suppl 2:S10
pubmed: 26063291
PLoS One. 2012;7(5):e35151
pubmed: 22615733
Glob Health Sci Pract. 2013 Jun 28;1(2):146-53
pubmed: 25276527

Auteurs

Archana B Patel (AB)

Lata Medical Research Foundation, Nagpur, India. dr_apatel@yahoo.com.
Datta Meghe Institute of Medical Sciences, Wardha, India. dr_apatel@yahoo.com.

Elizabeth M Simmons (EM)

School of Public Health, Boston University, Boston, MA, USA.

Sowmya R Rao (SR)

School of Public Health, Boston University, Boston, MA, USA.

Janet Moore (J)

RTI International, Durham, NC, USA.

Tracy L Nolen (TL)

RTI International, Durham, NC, USA.

Robert L Goldenberg (RL)

Department of Obstetrics and Gynecology, Columbia University School of Medicine, New York, NY, USA.

Shivaprasad S Goudar (SS)

KLE Academy Higher Education and Research, J N Medical College, Belagavi, Karnataka, India.

Manjunath S Somannavar (MS)

KLE Academy Higher Education and Research, J N Medical College, Belagavi, Karnataka, India.

Fabian Esamai (F)

Moi University School of Medicine, Eldoret, Kenya.

Paul Nyongesa (P)

Moi University School of Medicine, Eldoret, Kenya.

Ana L Garces (AL)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Elwyn Chomba (E)

University Teaching Hospital, Lusaka, Zambia.

Musaku Mwenechanya (M)

University Teaching Hospital, Lusaka, Zambia.

Sarah Saleem (S)

Aga Khan University, Karachi, Pakistan.

Farnaz Naqvi (F)

Aga Khan University, Karachi, Pakistan.

Melissa Bauserman (M)

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Sherri Bucher (S)

University of Indiana, Indianapolis, IN, USA.

Nancy F Krebs (NF)

University of Colorado School of Medicine, Denver, CO, USA.

Richard J Derman (RJ)

Thomas Jefferson University, Philadelphia, USA.

Waldemar A Carlo (WA)

University of Alabama at Birmingham, Birmingham, AL, USA.

Marion Elizabeth M Koso-ThomasMcClure (MEM)

RTI International, Durham, NC, USA.
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.

Patricia L Hibberd (PL)

School of Public Health, Boston University, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH